Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,437 public trials 2,853 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Not yet recruiting

Fluorescent Leukocytes as a Marker of Early Sepsis/Severity

NCT07585942

Conditions: Blood Coagulation Disorders, Disseminated Intravascular Coagulation, Disseminated Intravascular Coagulation (DIC), +13 more
Locations: The University Hospitals of Strasbourg, Intensive Care Medicine Department - New Civil Hospital Strasbourg, France

View Trial Details

Not yet recruiting

Minocycline In Neurocognitive Outcomes - Sickle Cell Disease

NCT05605366

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +21 more
Locations: Not specified

View Trial Details

Not yet recruiting

Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

NCT06954987

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not yet recruiting

BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation

NCT07583303

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Not yet recruiting

Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse

NCT06948084

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

Autologous Versus Allogeneic Hematopoietic Stem Cell Transplantation for T-Lymphoblastic Leukemia/Lymphoma in First Complete Remission

NCT07577531

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia

NCT07585071

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Trial Comparing Three Different Treatment Options for Adults With Low-Risk Myelodysplasia and Anemia (A MyeloMATCH Treatment Trial)

NCT07463820

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Not specified

View Trial Details

Not yet recruiting

Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT07582159

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, +16 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

View Trial Details

Not yet recruiting

A Study of SNH-119014 in Adult Participants With Non-transfusion-dependent Thalassemia (NTDT)

NCT07579949

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +6 more
Locations: Foshan First People's Hospital Foshan, Guangdong, China

Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

Maoming People's Hospital Maoming, Guangdong, China

Liuzhou People's Hospital Liuzhou, Guangxi, China

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions